BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 29802690)

  • 1. Therapeutic Use of Metformin in Diabetes and Survival Outcomes in Endometrial Cancer Patients with Diabetes.
    Insin P; Prueksaritanond N
    Asian Pac J Cancer Prev; 2018 May; 19(5):1295-1302. PubMed ID: 29802690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Metformin Use with Outcomes in Advanced Endometrial Cancer Treated with Chemotherapy.
    Ezewuiro O; Grushko TA; Kocherginsky M; Habis M; Hurteau JA; Mills KA; Hunn J; Olopade OI; Fleming GF; Romero IL
    PLoS One; 2016; 11(1):e0147145. PubMed ID: 26788855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of advanced or recurrent endometrial carcinoma with doxorubicin in patients progressing after paclitaxel/carboplatin: Memorial Sloan-Kettering Cancer Center experience from 1995 to 2009.
    Makker V; Hensley ML; Zhou Q; Iasonos A; Aghajanian CA
    Int J Gynecol Cancer; 2013 Jun; 23(5):929-34. PubMed ID: 23598889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Survival Outcomes of Uterine Papillary Serous Carcinoma, Clear Cell Carcinoma, Grade 3 Endometrioid Adenocarcinoma, and Carcinosarcoma of Endometrial Cancer in Rajavithi Hospital.
    Prueksaritanond N; Chantape W
    J Med Assoc Thai; 2016 Feb; 99 Suppl 2():S75-83. PubMed ID: 27266220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of chemotherapy-induced anemia in ovarian cancer patients: does the use of erythropoiesis-stimulating agents worsen survival?
    Rocconi RP; Sullivan P; Long B; Blaize M; Brown J; Arbuckle J; Bevis K; Estes JM; Reed E; Finan MA
    Int J Gynecol Cancer; 2012 Jun; 22(5):786-91. PubMed ID: 22552832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gemcitabine for advanced endometrial cancer: a retrospective study of the Memorial sloan-Kettering Cancer Center experience.
    Grisham RN; Adaniel C; Hyman DM; Ma W; Iasonos A; Aghajanian C; Konner J
    Int J Gynecol Cancer; 2012 Jun; 22(5):807-11. PubMed ID: 22635030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of metformin in the treatment of estrogen-dependent endometrial carcinoma complicated with type 2 diabetes mellitus and analysis of its prognosis.
    Deng Y; Wang J; Li W; Xiong W; Wang X
    J BUON; 2020; 25(3):1534-1540. PubMed ID: 32862601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of survival outcomes between patients with malignant mixed mullerian tumors and high-grade endometrioid, clear cell, and papillary serous endometrial cancers.
    Felix AS; Stone RA; Bowser R; Chivukula M; Edwards RP; Weissfeld JL; Linkov F
    Int J Gynecol Cancer; 2011 Jul; 21(5):877-84. PubMed ID: 21666484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uterine carcinosarcoma and high-risk endometrial carcinomas: a clinicopathological comparison.
    Zhang C; Hu W; Jia N; Li Q; Hua K; Tao X; Wang L; Feng W
    Int J Gynecol Cancer; 2015 May; 25(4):629-36. PubMed ID: 25633654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival of women with clear cell and papillary serous endometrial cancer after adjuvant radiotherapy.
    Foerster R; Kluck R; Rief H; Rieken S; Debus J; Lindel K
    Radiat Oncol; 2014 Jun; 9():141. PubMed ID: 24941899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical Treatment of Recurrent Endometrial Cancer: Time for a Paradigm Shift.
    Papadia A; Bellati F; Ditto A; Bogani G; Gasparri ML; Di Donato V; Martinelli F; Lorusso D; Benedetti-Panici P; Raspagliesi F
    Ann Surg Oncol; 2015 Dec; 22(13):4204-10. PubMed ID: 25777095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-operative assessment of muscle mass to predict surgical complications and prognosis in patients with endometrial cancer.
    Kuroki LM; Mangano M; Allsworth JE; Menias CO; Massad LS; Powell MA; Mutch DG; Thaker PH
    Ann Surg Oncol; 2015 Mar; 22(3):972-9. PubMed ID: 25190123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic role of metformin in patients with endometrial cancer: a retrospective study.
    Seebacher V; Bergmeister B; Grimm C; Koelbl H; Reinthaller A; Polterauer S
    Eur J Obstet Gynecol Reprod Biol; 2016 Aug; 203():291-6. PubMed ID: 27423029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "The impact of debulking surgery in patients with node-positive epithelial ovarian cancer: Analysis of prognostic factors related to overall survival and progression-free survival after an extended long-term follow-up period".
    Pereira A; Pérez-Medina T; Magrina JF; Magtibay PM; Rodríguez-Tapia A; Cuesta-Guardiola T; Peregrin I; Mendizabal E; Lizarraga S; Ortiz-Quintana L
    Surg Oncol; 2016 Mar; 25(1):49-59. PubMed ID: 26979641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Assessment of Prognostic Factors, Adjuvant Treatment, and Outcomes of Stage IA Polyp-Limited Versus Endometrium-Limited Type II Endometrial Carcinoma.
    Liang LW; Perez AR; Cangemi NA; Zhou Q; Iasonos A; Abu-Rustum N; Alektiar KM; Makker V
    Int J Gynecol Cancer; 2016 Mar; 26(3):497-504. PubMed ID: 26825840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant therapy in stage III endometrial cancer: treatment outcomes and survival. a single-institution retrospective study.
    Kuku S; Williams M; McCormack M
    Int J Gynecol Cancer; 2013 Jul; 23(6):1056-64. PubMed ID: 23765205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin Associates With Aggressive Features of Endometrial Cancer in Women With Type 2 Diabetes.
    Urpilainen E; Arima R; Karihtala P; Puistola U; Ahtikoski A
    Anticancer Res; 2021 Feb; 41(2):821-828. PubMed ID: 33517287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of the lymphadenectomy in high-risk histologic types of endometrial cancer: a matched-pair study.
    Coronado PJ; Fasero M; Baquedano L; Martinez-Maestre MA; Casado A; Vidart JA; Herraiz MA
    Int J Gynecol Cancer; 2014 May; 24(4):703-12. PubMed ID: 24651627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosine triphosphate-based chemotherapy response assay predicts long-term survival of primary epithelial ovarian cancer.
    Li LY; Kim SW; Nam EJ; Lee J; Kim S; Kim YT
    Int J Gynecol Cancer; 2019 Feb; 29(2):334-340. PubMed ID: 30718314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do endometrial cancer patients benefit from metformin intake?
    Lemańska A; Zaborowski M; Spaczyński M; Nowak-Markwitz E
    Ginekol Pol; 2015 Jun; 86(6):419-23. PubMed ID: 26255448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.